Stock Track | Rogers Stock Plummets 5.23% as New Gene Sequencing Device Threatens Illumina's Business

Stock Track

Feb 22, 2025

Rogers (ROG) stock experienced a significant plummet of 5.23% on Friday, February 21, 2025, during intraday trading session.

The sell-off in Rogers' shares was likely driven by concerns over the company's new gene sequencing device posing a threat to Illumina (ILMN), a leading player in the gene-sequencing equipment market. According to analysts at Bernstein, Roche's new device, unveiled on Thursday, outperforms Illumina's devices in providing detailed insights into genetics, genomics, and cell biology, potentially disrupting Illumina's dominance in the field.

While Bernstein raised questions about the accuracy of Roche's device, they acknowledged that it could be a serious threat to Illumina in some applications. Illumina's stock had already fallen 5.6% on Thursday following the news, and the company's shares have declined 24.8% in the past 12 months.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1177001278"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1177001278\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1177001278?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-22 03:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1177001278","market":"hk","top_or_hot":-1,"title":"Stock Track | Rogers Stock Plummets 5.23% as New Gene Sequencing Device Threatens Illumina's Business","media":"Stock Track","content":"<p>Rogers (ROG) stock experienced a significant plummet of 5.23% on Friday, February 21, 2025, during intraday trading session.</p>\n\n<p>The sell-off in Rogers' shares was likely driven by concerns over the company's new gene sequencing device posing a threat to Illumina (ILMN), a leading player in the gene-sequencing equipment market. According to analysts at Bernstein, Roche's new device, unveiled on Thursday, outperforms Illumina's devices in providing detailed insights into genetics, genomics, and cell biology, potentially disrupting Illumina's dominance in the field.</p>\n\n<p>While Bernstein raised questions about the accuracy of Roche's device, they acknowledged that it could be a serious threat to Illumina in some applications. Illumina's stock had already fallen 5.6% on Thursday following the news, and the company's shares have declined 24.8% in the past 12 months.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Rogers Stock Plummets 5.23% as New Gene Sequencing Device Threatens Illumina's Business</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Rogers Stock Plummets 5.23% as New Gene Sequencing Device Threatens Illumina's Business\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-22 03:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Rogers (ROG) stock experienced a significant plummet of 5.23% on Friday, February 21, 2025, during intraday trading session.</p>\n\n<p>The sell-off in Rogers' shares was likely driven by concerns over the company's new gene sequencing device posing a threat to Illumina (ILMN), a leading player in the gene-sequencing equipment market. According to analysts at Bernstein, Roche's new device, unveiled on Thursday, outperforms Illumina's devices in providing detailed insights into genetics, genomics, and cell biology, potentially disrupting Illumina's dominance in the field.</p>\n\n<p>While Bernstein raised questions about the accuracy of Roche's device, they acknowledged that it could be a serious threat to Illumina in some applications. Illumina's stock had already fallen 5.6% on Thursday following the news, and the company's shares have declined 24.8% in the past 12 months.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ROG","symbol_name":"罗杰斯","start_time":0,"source_url":"","article_id":"1177001278","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1177001278","pubTimestamp":1740166582,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Rogers  stock experienced a significant plummet of 5.23% on Friday, February 21, 2025, during intraday trading session.The sell-off in Rogers' shares was likely driven by concerns over the company's new gene sequencing device posing a threat to Illumina , a leading player in the gene-sequencing equipment market. According to analysts at Bernstein, Roche's new device, unveiled on Thursday, outperforms Illumina's devices in providing detailed insights into genetics, genomics, and cell biology, pot","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ROG":"罗杰斯"},"translate_title":"股票轨迹新基因测序设备威胁Illumina业务罗杰斯股价暴跌5.23%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ROG":1},"content_text":"Rogers (ROG) stock experienced a significant plummet of 5.23% on Friday, February 21, 2025, during intraday trading session.\nThe sell-off in Rogers' shares was likely driven by concerns over the company's new gene sequencing device posing a threat to Illumina (ILMN), a leading player in the gene-sequencing equipment market. According to analysts at Bernstein, Roche's new device, unveiled on Thursday, outperforms Illumina's devices in providing detailed insights into genetics, genomics, and cell biology, potentially disrupting Illumina's dominance in the field.\nWhile Bernstein raised questions about the accuracy of Roche's device, they acknowledged that it could be a serious threat to Illumina in some applications. Illumina's stock had already fallen 5.6% on Thursday following the news, and the company's shares have declined 24.8% in the past 12 months.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}